Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reversal of signs and symptoms of a B-cell lymphoma in a patient using only low-dose naltrexone.

× No keyword cloud information.

5 in total

1. Selective opioid growth factor receptor antagonists based on a stilbene isostere.

Authors: David P Stockdale; Michelle B Titunick; Jessica M Biegler; Jessie L Reed; Alyssa M Hartung; David F Wiemer; Patricia J McLaughlin; Jeffrey D Neighbors
Journal: Bioorg Med Chem Date: 2017-06-27 Impact factor: 3.641

Review 2. Naltrexone's Impact on Cancer Progression and Mortality: A Systematic Review of Studies in Humans, Animal Models, and Cell Cultures.

Authors: Karina Liubchenko; Kevin Kordbacheh; Nika Khajehdehi; Tanja Visnjevac; Frederick Ma; James S Khan; Myles Storey; Alaa Abd-Elsayed; Ognjen Visnjevac
Journal: Adv Ther Date: 2020-12-18 Impact factor: 3.845

3. Naltrexone Inhibits IL-6 and TNFα Production in Human Immune Cell Subsets following Stimulation with Ligands for Intracellular Toll-Like Receptors.

Authors: Rachel Cant; Angus G Dalgleish; Rachel L Allen
Journal: Front Immunol Date: 2017-07-11 Impact factor: 7.561

4. The Long-Term Survival of a Patient With Stage IV Renal Cell Carcinoma Following an Integrative Treatment Approach Including the Intravenous α-Lipoic Acid/Low-Dose Naltrexone Protocol.

Authors: Burton M Berkson; Francisco Calvo Riera
Journal: Integr Cancer Ther Date: 2017-12-19 Impact factor: 3.279

Review 5. Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction?

Authors: Amparo Belltall; Guido Mazzinari; Oscar Diaz-Cambronero; Pilar Eroles; María Pilar Argente Navarro
Journal: Curr Oncol Rep Date: 2022-06-01 Impact factor: 5.945

5 in total